Stockscreener 앱 받기
0.9297
3.17%
-0.0304
시간 외 거래:
.91
-0.0197
-2.12%
전일 마감가:
$0.9601
열려 있는:
$0.94
하루 거래량:
56,543
Relative Volume:
0.14
시가총액:
$2.01M
수익:
$31,800
순이익/손실:
$-37.83M
주가수익비율:
-1.3094
EPS:
-0.71
순현금흐름:
$-30.64M
1주 성능:
-15.48%
1개월 성능:
-41.53%
6개월 성능:
-97.51%
1년 성능:
-98.69%
1일 변동 폭
$0.90
$0.96
1주일 범위
$0.90
$1.19
52주 변동 폭
$0.90
$124.80
Eyenovia Inc Stock (EYEN) Company Profile
명칭
Eyenovia Inc
전화
813-766-9539
주소
295 MADISON AVENUE,, NEW YORK, NY
EYEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
0.9297 | 2.01M | 31,800 | -37.83M | -30.64M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.56 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.78 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
550.00 | 33.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.95 | 30.15B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
220.54 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-03-01 | 개시 | Northland Capital | Outperform |
| 2020-02-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
Eyenovia Inc 주식(EYEN)의 최신 뉴스
Eyenovia Inc expected to post a loss of $7.20 a shareEarnings Preview - TradingView
Eyenovia Delays Yearly Report Filing - TipRanks
Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq - insights.citeline.com
Eyenovia falls on plans to seek reverse merger - MSN
Eyenovia Enters Into Non-Binding Letter of Intent to Effect Reverse Merger With Betaliq - VisionMonday.com
Eyenovia And Betaliq Announce Potential Reverse Merger - Nasdaq
Eyenovia Shares Drop 14% Amid Betaliq Merger Talks - Yahoo
Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ) - Seeking Alpha
Eyenovia falls after plans to merge with private firm Betaliq - TradingView
Eyenovia Plans All-Stock Reverse Merger With Betaliq - MarketWatch
Eyenovia and Betaliq Explore Merger to Form New Ophthalmic Company Combining Innovative Drug Delivery Technologies for Glaucoma Treatment - Nasdaq
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewswire
Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery - StockTitan
EYENOVIA Earnings Preview: Recent $EYEN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Eyenovia, Inc. to Host Earnings Call - ACCESS Newswire
Eyenovia regains compliance with Nasdaq - MSN
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewswire
Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On? - Benzinga
Eyenovia regains Nasdaq compliance, eyes strategic options By Investing.com - Investing.com Canada
Eyenovia regains Nasdaq compliance, eyes strategic options - Investing.com India
Eyenovia shareholders approve reverse stock split and additional stock reserve - MSN
Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer? - StockTitan
Eyenovia regains Nasdaq compliance with stock bid price By Investing.com - Investing.com Australia
Eyenovia regains Nasdaq compliance with stock bid price - Investing.com
Eyenovia, Inc. Announces Debt Restructuring, Including Amendment to Senior Secured Debt to Improve Liquidity - Vision Monday
Eyenovia defers debt payments to bolster liquidity By Investing.com - Investing.com Nigeria
Eyenovia announces debt restructuring, improving cash runway - MSN
Eyenovia, Inc. Announces Debt Restructuring Including - GlobeNewswire
Eyenovia defers loan payments, may convert debt to equity By Investing.com - Investing.com Canada
Eyenovia defers loan payments, may convert debt to equity - Investing.com India
Eyenovia defers debt payments to bolster liquidity - Investing.com India
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - The Manila Times
Eyenovia, Inc. Announces Amendment to Senior Secured Convertible Debt to Enhance Liquidity and Support Optejet® Development - Nasdaq
Can This Biotech's Debt Restructuring Lead to a Strategic Sale? - StockTitan
FY2025 EPS Estimates for Eyenovia Boosted by HC Wainwright - Defense World
Eyenovia Inc’s (EYEN) Stock: A -58.29% Simple Moving Average for the Past 20 Days - The News Heater
Wainwright maintains neutral Eyenovia stock, $2 target - MSN
Wainwright maintains neutral Eyenovia stock, $2 target By Investing.com - Investing.com Canada
Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewswire
The Attractiveness of Investing In Eyenovia Inc (EYEN) is Growing - Knox Daily
Eyenovia, Inc. Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - Marketscreener.com
Revolutionary Eye Drop Spray Shows Perfect Precision: Eyenovia's Game-Changing Solution for Millions - StockTitan
Eyenovia enacts reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Australia
Eyenovia enacts reverse stock split to meet Nasdaq requirements - Investing.com
Eyenovia Inc (EYEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
자본화:
|
볼륨(24시간):